Page last updated: 2024-09-02

kt 6149 and Bone Marrow Diseases

kt 6149 has been researched along with Bone Marrow Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ardiet, C; Catimel, G; De Bruijn, E; Dirix, L; Dumortier, A; Evene, E; Joossens, E; Koier, I; Provè, A; Schrijvers, D	1
Ashizawa, T; Gomi, K; Hirata, T; Okabe, M	1

Trials

1 trial(s) available for kt 6149 and Bone Marrow Diseases

Article	Year
Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149. Anti-cancer drugs, 1995, Volume: 6, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Biotransformation; Bone Marrow Diseases; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Diseases; Half-Life; Humans; Liver Neoplasms; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasms; Neoplasms, Unknown Primary; Salvage Therapy	1995

Article

Year

Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149.

Anti-cancer drugs, 1995, Volume: 6, Issue:1

Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Biotransformation; Bone Marrow Diseases; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Diseases; Half-Life; Humans; Liver Neoplasms; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasms; Neoplasms, Unknown Primary; Salvage Therapy

1995

Other Studies

1 other study(ies) available for kt 6149 and Bone Marrow Diseases

Article	Year
Reduced bone marrow toxicity of KW-2149, a mitomycin C derivative, in mice. Anti-cancer drugs, 1993, Volume: 4, Issue:2 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Blood Cell Count; Bone Marrow Diseases; Colony-Forming Units Assay; Female; Hematopoietic Stem Cells; Lung Diseases; Male; Megakaryocytes; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Mitomycin; Mitomycins; Organ Size; Spleen; Tumor Cells, Cultured	1993

Article

Year

Reduced bone marrow toxicity of KW-2149, a mitomycin C derivative, in mice.

Anti-cancer drugs, 1993, Volume: 4, Issue:2

Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Blood Cell Count; Bone Marrow Diseases; Colony-Forming Units Assay; Female; Hematopoietic Stem Cells; Lung Diseases; Male; Megakaryocytes; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Mitomycin; Mitomycins; Organ Size; Spleen; Tumor Cells, Cultured

1993